← Back to Directory

Hearing Aid

Personal Sound Amplification Product, PSAP, Cochlear Implant

Visual ViewRaw Data

Meta Information

ID:hearing-aid
Name:Hearing Aid
Schema Version:1.5

Alternate Names

  • Personal Sound Amplification Product
  • PSAP
  • Cochlear Implant

Active Compound

null

Intervention Type

device

Delivery

Route:
none
Scope:
  • local

Regulatory Status

  • us:medical_device
  • us:otc_medical_device

Indication

Focus:
  • healthspan
  • symptom_management
Description:
To correct age-related hearing loss (presbycusis) and mitigate associated risks of cognitive decline, dementia, and social isolation.

Typical Protocol

  • Worn daily during waking hours as needed for effective communication and environmental awareness.

Expected Cost Mean

Low Cost:
200
High Cost:
6000
Cost Type:
equipment
Description:
One-time cost for a pair; may be partially covered by insurance/Medicare Advantage.

Summary

Hearing aids are electronic devices that amplify sound for individuals with hearing loss. By restoring auditory input, they reduce the cognitive load associated with straining to hear, which is hypothesized to free up cognitive resources. This intervention is strongly linked to decreased risk of social isolation, depression, and accelerated cognitive decline, making it a critical tool for maintaining brain health and quality of life in older age.

Purpose

Corrects hearing loss to reduce cognitive decline risk.

Card Summary

A wearable device that amplifies sound to correct hearing loss, significantly reducing the associated risk of cognitive decline, dementia, and social isolation.

Drug Class

null

Drugs In Class

Empty Array

Impact

Score:
7.5
Justification:
Strongly mitigates a major modifiable risk factor for dementia and social isolation.

Evidence

Grade:
A
Score:
9
Justification:
Large observational studies and a major RCT (ACHIEVE trial) support cognitive benefits.

Safety

Score:
1
Justification:
Non-invasive external device with minimal risks, primarily related to fit and volume.

Flags

  • Initial adjustment period may be required for the brain to adapt.
  • Over-the-counter options may be less effective for severe or complex hearing loss.
  • Requires regular cleaning and maintenance for optimal function.

Verdict

A high-impact, low-risk intervention to protect long-term brain health.

Created

2026-05-06T16:39:12.812978Z

Ai Model

Gemini 2.5 Pro (High)